📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Improving our Understanding of Early Psychosis: Learning from the Optimise Trial (2023)

First Author: Lennox B

Attributed to: A randomised placebo-controlled trial of immunotherapy in patients with psychosis associated with anti-neuronal membrane antibodies (SINAPPS 2) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/schbul/sbad061

PubMed Identifier: 37159930

Publication URI: http://europepmc.org/abstract/MED/37159930

Type: Journal Article/Review

Parent Publication: Schizophrenia Bulletin

Issue: 4

ISSN: 0586-7614